Research & Projects

ESCMID Panorama

Presentations & Publications

2019

ESGEM

 

A Europe-wide study that describes the transmission dynamics of carbapenem-resistant Klebsiella pneumoniae isolates was carried out in collaboration with the ESCMID Study Group on Molecular Epidemiologic Markers (ESGEM), the Centre for Genomic Pathogen Surveillance, based at the Wellcome Sanger Institute and the University of Freiburg, Germany. Researchers analysed the genomes of almost 2,000 K. pneumoniae samples taken from the European Survey on Carbapenamase-Producing Enterobacteriaceae (EuSCAPE) originally funded by the European Centres for Disease Prevention and Control (ECDC). Clinical isolates were from patients in 244 hospitals in 32 countries. The results, published in Nature Microbiology, will inform public health efforts to control the spread of these infections in hospitals at national levels. The survey is the largest of its kind and is the first step towards  standardised surveillance of carbapenem-resistant bacteria on a pan-European scale. Resistance against carbapenems (CR) is far more frequent in K. pneumoniae than in other Enterobacteriaceae, and outnumbers CR-Escherichia coli 11:1. It is currently also the fastest growing resistance problem in Europe and since carbapenems are regarded as a ‘last-line’ antibiotic reserved for the treatment of multidrug-resistant strains, carbapenem-resistant isolates are often classified as extremely drug resistant (XDR).
Resistant isolates showed a remarkably constrained genetic diversity whereby 70% of CR-K. pneumoniae were concentrated in only four clonal lineages, all of them bearing the hallmarks of so called ‘high risk’ clones. Moreover, there was a strong correlation between genetic and geographic distance with 52% of the genetically nearest neighbours co-circulating among patients treated in the same hospital. Combined analysis of the genetic and geographic distances between isolates with different β-lactam resistance determinants suggests that the propensity of K. pneumoniae to spread between patients correlates with the degree of resistance and that carbapenemase-positive isolates have the highest transmissibility. The authors conclude (i) that the epidemic of carbapenem-resistant K. pneumoniae is driven by a nosocomial expansion of few hospital adapted clones, (ii) that antibiotic use is the most important effect modifier, and (iii) that OneHealth reservoirs are not likely to explain the observed pattern.    

2016

5 May 2016 mBio vol. 7 no. 3 e00444-16; doi: 10.1128/mBio.00444-16

 

In this ESGEM paper, we combined WGS data from 308 invasive Staphylococcus aureus isolates corresponding to a pan-European population snapshot, with epidemiological and resistance data. We argue that this work provides a comprehensive road map illustrating the three vital components for future molecular epidemiological surveillance: (i) large-scale structured surveys, (ii) WGS, and (iii) community-oriented database infrastructure and analysis tools.